FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
DALMANE
flurazepam hydrochloride
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
insomnia characterized by difficulty falling asleepfrequent nocturnal awakenings+2
1970
NDA
30/100
DANOCRINE
danazol
LOE Approaching
Sanofi
ORAL · CAPSULE
endometriosis amenable to hormonal managementattacks of angioedema of all types (cutaneous+3
1976
NDA
30/100
DANTRIUM
dantrolene sodium
LOE Approaching
Pfizer
ORAL · CAPSULE
controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (ethe treatment of skeletal muscle spasm resulting from rheumatic disorders+2
1974
NDA
30/100
DANTRIUM
dantrolene sodium
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1979
NDA
30/100
DAPIPRAZOLE HYDROCHLORIDE
dapiprazole hydrochloride
LOE Approaching
OPHTHALMIC · SOLUTION/DROPS
1990
NDA
30/100
DARANIDE
dichlorphenamide
LOE Approaching
ORAL · TABLET
primary hyperkalemic periodic paralysisprimary hypokalemic periodic paralysis+1
1958
NDA
30/100
DARAPRIM
pyrimethamine
LOE Approaching
ORAL · TABLET
toxoplasmosissince synergism exists with this combination
1953
NDA
30/100
DARBID
isopropamide iodide
LOE Approaching
GSK
ORAL · TABLET
1957
NDA
30/100
DARVOCET
acetaminophen; propoxyphene hydrochloride
LOE Approaching
ORAL · TABLET
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1972
NDA
30/100
DARVOCET-N 100
acetaminophen; propoxyphene napsylate
LOE Approaching
ORAL · TABLET
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1972
NDA
30/100
DARVOCET-N 50
acetaminophen; propoxyphene napsylate
LOE Approaching
ORAL · TABLET
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1972
NDA
30/100
DARVON
propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA
30/100
DARVON COMPOUND
aspirin; caffeine; propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA
30/100
DARVON COMPOUND-65
aspirin; caffeine; propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA
30/100
DARVON W/ ASA
aspirin; propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA
30/100
DARVON-N
propoxyphene napsylate
LOE Approaching
ORAL · TABLET
1971
NDA
30/100
DARVON-N
propoxyphene napsylate
LOE Approaching
ORAL · SUSPENSION
1971
NDA
30/100
DARVON-N W/ ASA
aspirin; propoxyphene napsylate
LOE Approaching
ORAL · TABLET
1971
NDA
30/100
DARVON-N W/ ASA
aspirin; propoxyphene napsylate
LOE Approaching
ORAL · CAPSULE
1971
NDA
30/100
DATSCAN
ioflupane i-123
LOE Approaching
INTRAVENOUS · SOLUTION
2011
NDA
30/100
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
LOE Approaching
Hikma
INJECTION · INJECTABLE
leukemia
1998
NDA
30/100
DAUNOXOME
daunorubicin citrate
LOE Approaching
INJECTION · INJECTABLE, LIPOSOMAL
1996
NDA
30/100
DAYPRO
oxaprozin
LOE Approaching
Pfizer
ORAL · TABLET
rheumatoid arthritis
1992
NDA
30/100
DAYPRO ALTA
oxaprozin potassium
LOE Approaching
Pfizer
ORAL · TABLET
2002
NDA
30/100
← PreviousPage 40 of 188Next →